UPC_APP_36130/2024

The President of the Court of First Instance granted Tandem Diabetes Care's application to change the language of proceedings from German to English (the language in which the patent was granted) in an infringement action brought by Roche Diabetes Care GmbH. The court found that where the balance of interests between the parties was equal (both being international companies), the position of the defendant was the decisive factor.